Use of Blended Oxygen for Delivery Room Resuscitation of Very Low Birth Weight Infants
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
We propose a preliminary trial to evaluate the safety and efficacy of using more restricted oxygen during resuscitation for VLBW infants than is utilized currently in an effort to reduce the oxidant stress of such treatment, and to possibly reduce associated multi-system organ related dysfunction.
In attempting to design a trial comparing higher versus lower oxygen during neonatal resuscitation with the potential for benefit to the enrolled infants, and a minimal level of risk, and acknowledging that the use of Room Air may be considered premature in view of the lack of any safety data in this population, we are proposing to utilize an oxygen blender and a pulse oximeter in the delivery room in the treated group. The treated group will have their fraction of inspired oxygen increased from 21%, as necessary, to achieve a target oxygen saturation of 85 to 90% at 5 minutes of life, compared with the standard of care group who will receive 100% oxygen without the use of a blender, which is the current approach in most centers in this country. The targeted saturation of 85% will provide enough oxygen to treat any ventilation/perfusion mismatch, while exposing the infants to significantly less inspired oxygen.
Hypothesis: We hypothesize that the use of restricted inspired oxygen during resuscitation will result in a significant reduction in oxidant stress without any harmful clinical effects.
| Condition | Intervention |
|---|---|
|
Prematurity Oxidant Injury |
Procedure: Titration of oxygen in delivery room |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Use of Blended Oxygen for Delivery Room Resuscitation of VLBW Infants |
- total antioxidant status
- lipid peroxide levels
- oxygen saturations
- Days on oxygen
- Days on conventional ventilation
- Days on high frequency ventilation
- Days on nasal canula
- Pneumothorax
- Oxygen requirement at 36 weeks adjusted age
- Patent ductus arteriosus
- Patent ductus arteriosus requiring ligation
- Necrotizing Enterocolitis
- Surgery for necrotizing enterocolitis
- Isolated gastrointestinal perforation
- Intracranial hemorrhage
- Periventricular leukomalacia
- Retinopathy
- Death
| Estimated Enrollment: | 40 |
| Study Start Date: | January 2005 |
| Estimated Study Completion Date: | January 2008 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 23 Weeks to 32 Weeks |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- inborn infant
- gestation 23 weeks to 31 weeks 6 days
Exclusion Criteria:
- known chromosomal or congenital anomalies
Contacts and Locations| United States, California | |
| University of California San Diego Medical Center | |
| San Diego, California, United States, 92103 | |
| Principal Investigator: | Neil N Finer, MD | University of California, San Diego |
More Information
No publications provided by University of California, San Diego
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00369720 History of Changes |
| Other Study ID Numbers: | 051169 |
| Study First Received: | August 28, 2006 |
| Last Updated: | April 18, 2007 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of California, San Diego:
|
Prematurity Resuscitation Room Air |
ClinicalTrials.gov processed this record on May 16, 2013